Modular Cleanrooms for Flexible Biotherapeutic Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing biotherapeutic production facilities lack flexibility and efficiency due to inflexible equipment arrangements and ad hoc process modifications, leading to high costs and limited molecule production capabilities, with data from one facility often not applicable to others.
Innovation Solution
Implement modular cleanrooms with adaptable equipment and machine learning-based control systems to optimize production processes, allowing multiple biotherapeutics to be produced without significant capital expenditure, and utilize single-use materials to minimize contamination and maintenance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If equipment is arranged according to a specific footprint in production facilities, then manufacturing precision is improved, but adaptability deteriorates
Solution Approach 1:
The production facility is divided into modular cleanrooms that can be independently configured. Each modular unit contains standardized equipment modules that can be assembled in different arrangements to produce different biotherapeutics, maintaining precision while enabling adaptability through modular reconfiguration.
Solution Approach 2:
The equipment arrangement is made dynamic through modular design, allowing the production line to be reconfigured for different molecules. The modular cleanrooms and equipment modules can be moved and repositioned to optimize production for different therapeutic products without requiring complete facility redesign.
2Manufacturing precision
If production lines are customized for specific molecules, then manufacturing precision is improved, but device complexity increases
Solution Approach 1:
Standardized equipment modules are designed to perform multiple functions across different biotherapeutic production processes. The same module types can be used for different molecules by changing process parameters and configurations, reducing overall system complexity while maintaining molecule-specific optimization.
Solution Approach 2:
Instead of physically redesigning equipment for different molecules, the system optimizes production by changing operational parameters, process conditions, and software configurations of standardized modules. This allows precise control for different therapeutic products without increasing physical device complexity.
3Manufacturing precision
If multiple molecules are produced in separate facilities, then manufacturing precision is improved, but loss of time increases
Solution Approach 1:
A single facility with modular cleanrooms is designed to produce multiple biotherapeutics using the same infrastructure. Different molecular productions share common support systems, utilities, and equipment modules, eliminating the need to construct separate facilities for each molecule while maintaining production precision through standardized modular units.
Solution Approach 2:
The modular facility is pre-configured with standardized equipment modules and infrastructure that can accommodate multiple biotherapeutic production lines. This preliminary setup allows rapid deployment of new production capabilities without extensive construction or modification time, as modules can be quickly installed and configured for different molecules.
Data Source
AI summary
The concepts described herein are directed to implementations of production facilities that can produce molecules used to treat biological conditions, such as biotherapeutics. The biotherapeutics can include various molecules, such as proteins, enzymes, and antibodies. The production facilities can include a number of separate modular cleanrooms that comprise particular pieces of equipment to perform one or more aspects of the processes used to manufacture biotherapeutics. The modular cleanrooms are arranged such that material that is produced by the equipment of one modular cleanroom can be transferred to another modular cleanroom for additional processing. Additionally, systems and processes are described to generate models using machine learning techniques, where the models can be used to predict productivity and/or efficiency metrics for production lines of biotherapeutics. Further, models can be generated to control the operation of pieces of equipment included in the production lines.